John Pennett is the Partner-in-Charge of the Life Sciences Group and Technology Group.  He has more than 25 years of public accounting experience with a strong emphasis on public and private life sciences companies.  John is a frequent writer and speaker on topics related to issues impacting businesses in the life sciences and technology space. He is the publisher of Catalyst, a magazine focused solely on issues related to life sciences and pharmaceutical companies.  John also serves on the firm’s Public Companies Group.

John is a member of the American Institute of Certified Public Accountants (AICPA) and New Jersey Society of Certified Public Accountants (NJSCPA), where he serves on the Cooperation with Bankers Committee.  He is also a member of BioNJ, where he is co-chair of the CFO Committee; New Jersey Technology Council (NJTC); Pennsylvania Bio; and the Accounting Advisory Board of the Rutgers University School of Business.  In addition, John is on the advisory board of the Commercialization Center for Innovative Technologies (CCIT) and the Business Development Incubator at New Jersey City University (NJCU).  He is a graduate of Rutgers University and previously worked as audit partner for an international accounting and consulting firm.